These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8299923)

  • 1. Mesalazine as maintenance treatment in Crohn's disease.
    Vos J; Lesterhuis W
    Gastroenterology; 1994 Feb; 106(2):553-4. PubMed ID: 8299923
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of mesalazine in Crohn's disease.
    Hanauer SB
    Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
    Sahmoud T; Mary JY; Sahmoud T
    Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH; Hemphill D; Greenberg GR
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
    Tremaine WJ
    Gastroenterology; 1992 Aug; 103(2):694-6. PubMed ID: 1353043
    [No Abstract]   [Full Text] [Related]  

  • 6. Second trial of mesalamine therapy in the treatment of active Crohn's disease.
    Singleton J
    Gastroenterology; 1994 Aug; 107(2):632-3. PubMed ID: 8039647
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Crohn's disease with 5-ASA.
    Katz J
    Am J Gastroenterol; 1993 Sep; 88(9):1315-7. PubMed ID: 8362823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mesalazine in Crohn disease].
    Linnestad P
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3252. PubMed ID: 2256041
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current salazosulfapyridine derivatives in the treatment of Crohn's disease].
    Belaiche J; Delwaide J; Louis E; Gast P
    Rev Med Liege; 1991 Jan; 46(1):16-22. PubMed ID: 2011676
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-Aminosalicylates for prevention of recurrence in patients with Crohn's disease: time for a reappraisal?
    Sutherland LR
    J Clin Gastroenterol; 1991 Feb; 13(1):5-7. PubMed ID: 2007746
    [No Abstract]   [Full Text] [Related]  

  • 12. Is maintenance therapy effective in Crohn's disease?
    Greenberger NJ; Miner PB
    Lancet; 1994 Oct; 344(8927):900-1. PubMed ID: 7934340
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintaining remission of Crohn's disease.
    Novak E
    CMAJ; 1988 Jul; 139(1):14. PubMed ID: 3383034
    [No Abstract]   [Full Text] [Related]  

  • 14. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE; Helmstädter V
    Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
    Netzer P
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Crohn's disease with peroral 5-aminosalicylic acid.
    Rasmussen SN; Binder V; Maier K; Bondesen S; Fischer C; Klotz U; Hansen SH; Hvidberg EF
    Gastroenterology; 1983 Dec; 85(6):1350-3. PubMed ID: 6354827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
    Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
    Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute pancreatitis in Crohn's disease due to 5-ASA therapy.
    Radke M; Bartolomaeus G; Müller M; Richter I
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):337-9. PubMed ID: 8492268
    [No Abstract]   [Full Text] [Related]  

  • 19. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F
    Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
    Gendre JP; Mary JY; Florent C; Modigliani R; Colombel JF; Soulé JC; Galmiche JP; Lerebours E; Descos L; Viteau JM
    Ann Gastroenterol Hepatol (Paris); 1993 Oct; 29(5):251-6. PubMed ID: 8250520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.